On January 7, 2026, Phathom Pharmaceuticals, Inc. announced an underwriting agreement to issue 6,875,000 shares of common stock at $16.00 each, expecting to raise approximately $130 million, potentially $150 million if additional shares are purchased. The offering is set to close on January 9, 2026.